Inflection Point Acquisition Corp. IV filings document its blank-check issuer structure, SPAC security disclosures, material agreements, shareholder voting matters, and capital structure. The filing record includes registration-statement materials and Form 8-K material-event reports that address securities, governance, risk factors, and operating or financial results.
For a SPAC issuer such as BACQU, these disclosures describe the formal mechanics of its public securities and corporate actions, including unit, warrant, rights and related capital-structure matters, along with governance and shareholder-approval topics recorded in SEC filings.
Inflection Point Acquisition Corp. notified the removal of its Rights, Units from listing and registration on the Nasdaq Stock Market LLC. The Form 25 cites Nasdaq compliance with 17 CFR 240.12d2-2 and the issuer's compliance with the Exchange's rules for voluntary withdrawal; an expiry date appears as March 31, 2018.
Inflection Point Acquisition Corp. notified the removal of its Rights, Units from listing and registration on the Nasdaq Stock Market LLC. The Form 25 cites Nasdaq compliance with 17 CFR 240.12d2-2 and the issuer's compliance with the Exchange's rules for voluntary withdrawal; an expiry date appears as March 31, 2018.
Inflection Point Acquisition Corp. IV reported that shareholders approved all proposals presented at an extraordinary general meeting connected to its planned business combination with Merlin Labs, Inc., as described in its proxy statement/prospectus. The meeting achieved a quorum with 20,358,101 ordinary shares, or 60.31% of those outstanding as of February 2, 2026, represented in person or by proxy.
Each proposal received substantially more votes "for" than "against," and the company did not need to use an adjournment proposal because support levels were sufficient. Shareholders also backed the company’s slate of directors, with each nominee receiving significantly more votes "for" than votes withheld.
Inflection Point Acquisition Corp. IV reported that shareholders approved all proposals presented at an extraordinary general meeting connected to its planned business combination with Merlin Labs, Inc., as described in its proxy statement/prospectus. The meeting achieved a quorum with 20,358,101 ordinary shares, or 60.31% of those outstanding as of February 2, 2026, represented in person or by proxy.
Each proposal received substantially more votes "for" than "against," and the company did not need to use an adjournment proposal because support levels were sufficient. Shareholders also backed the company’s slate of directors, with each nominee receiving significantly more votes "for" than votes withheld.
INFLECTION POINT ACQUISITION CORP. IV reported mixed insider trading activity by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC in its Class A common stock. Between November 28 and December 9, 2025, Goldman Sachs, acting as a market maker, executed multiple open-market purchases and sales.
The transactions totaled 4,328 shares purchased and 4,872 shares sold, for a small net sale of 544 shares, at prices generally around $10.71–$11.00 per share. After these trades, indirect ownership stood at roughly 3.25 million shares.
The common stock is held directly by Goldman Sachs and indirectly by The Goldman Sachs Group, Inc., which disclaim beneficial ownership except to any pecuniary interest. They state that any profit potentially recoverable under Section 16(b) from these trades will be remitted to the issuer, and that on February 5, 2026, they ceased to be greater-than-10% beneficial owners of the Class A common stock.
INFLECTION POINT ACQUISITION CORP. IV reported mixed insider trading activity by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC in its Class A common stock. Between November 28 and December 9, 2025, Goldman Sachs, acting as a market maker, executed multiple open-market purchases and sales.
The transactions totaled 4,328 shares purchased and 4,872 shares sold, for a small net sale of 544 shares, at prices generally around $10.71–$11.00 per share. After these trades, indirect ownership stood at roughly 3.25 million shares.
The common stock is held directly by Goldman Sachs and indirectly by The Goldman Sachs Group, Inc., which disclaim beneficial ownership except to any pecuniary interest. They state that any profit potentially recoverable under Section 16(b) from these trades will be remitted to the issuer, and that on February 5, 2026, they ceased to be greater-than-10% beneficial owners of the Class A common stock.
Inflection Point Acquisition Corp. IV filed an 8-K highlighting a press release from Merlin Labs, Inc., its proposed merger partner, announcing an Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET. The event will feature a presentation and Q&A with Merlin’s management, with a replay available on Merlin’s investor relations website.
The filing reiterates that Inflection Point and Merlin entered into a Business Combination Agreement on August 13, 2025 and that a Form S-4 registration statement with a proxy statement/prospectus has been filed and mailed to Inflection Point shareholders for their vote on the business combination. Merlin is described as an aerospace and defense technology company focused on autonomous flight, supported by $100M+ total in awarded contracts from military customers.
Inflection Point Acquisition Corp. IV filed an 8-K highlighting a press release from Merlin Labs, Inc., its proposed merger partner, announcing an Investor & Analyst Webinar on March 3, 2026 at 1:00pm ET. The event will feature a presentation and Q&A with Merlin’s management, with a replay available on Merlin’s investor relations website.
The filing reiterates that Inflection Point and Merlin entered into a Business Combination Agreement on August 13, 2025 and that a Form S-4 registration statement with a proxy statement/prospectus has been filed and mailed to Inflection Point shareholders for their vote on the business combination. Merlin is described as an aerospace and defense technology company focused on autonomous flight, supported by $100M+ total in awarded contracts from military customers.
Merus Global Investments, LLC filed an amended Schedule 13G reporting a passive ownership position in Inflection Point Acquisition Corp. IV Class A ordinary shares. Merus beneficially owns 1,725,000 shares, representing 6.9% of the class, based on 25,000,000 shares outstanding as of February 2, 2026.
Merus reports sole voting and dispositive power over all 1,725,000 shares and no shared power. The firm certifies the securities were not acquired to change or influence control of the issuer, indicating a non‑control, investment-focused holding as of the December 31, 2025 event date.
Merus Global Investments, LLC filed an amended Schedule 13G reporting a passive ownership position in Inflection Point Acquisition Corp. IV Class A ordinary shares. Merus beneficially owns 1,725,000 shares, representing 6.9% of the class, based on 25,000,000 shares outstanding as of February 2, 2026.
Merus reports sole voting and dispositive power over all 1,725,000 shares and no shared power. The firm certifies the securities were not acquired to change or influence control of the issuer, indicating a non‑control, investment-focused holding as of the December 31, 2025 event date.
Highbridge Capital Management, LLC filed a Schedule 13G reporting a significant passive ownership position in Inflection Point Acquisition Corp. IV. Highbridge, as investment adviser to certain funds and accounts, reported beneficial ownership of 2,011,897 Class A ordinary shares.
This stake represents 7.9% of the Class A ordinary shares outstanding, based on 25,425,000 Class A ordinary shares outstanding as of November 12, 2025, as disclosed by the issuer. Highbridge reported sole voting and sole dispositive power over the 2,011,897 shares, with no shared voting or dispositive power.
The filing notes that the shares are directly held by funds it advises, including Highbridge Tactical Credit Master Fund, L.P., which alone has the right to receive dividends or sale proceeds from more than 5% of the outstanding Class A ordinary shares. Highbridge certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Highbridge Capital Management, LLC filed a Schedule 13G reporting a significant passive ownership position in Inflection Point Acquisition Corp. IV. Highbridge, as investment adviser to certain funds and accounts, reported beneficial ownership of 2,011,897 Class A ordinary shares.
This stake represents 7.9% of the Class A ordinary shares outstanding, based on 25,425,000 Class A ordinary shares outstanding as of November 12, 2025, as disclosed by the issuer. Highbridge reported sole voting and sole dispositive power over the 2,011,897 shares, with no shared voting or dispositive power.
The filing notes that the shares are directly held by funds it advises, including Highbridge Tactical Credit Master Fund, L.P., which alone has the right to receive dividends or sale proceeds from more than 5% of the outstanding Class A ordinary shares. Highbridge certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Inflection Point Acquisition Corp. IV received an updated Schedule 13G/A showing institutional holders reporting small, non‑controlling stakes in its Class A ordinary shares. As of December 31, 2025, First Trust Merger Arbitrage Fund reported beneficial ownership of 492,451 Ordinary Shares, or about 1.93% of the class. First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC collectively reported beneficial ownership of 593,278 Ordinary Shares, or 2.33% of the class. The filers state the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Inflection Point Acquisition Corp. IV received an updated Schedule 13G/A showing institutional holders reporting small, non‑controlling stakes in its Class A ordinary shares. As of December 31, 2025, First Trust Merger Arbitrage Fund reported beneficial ownership of 492,451 Ordinary Shares, or about 1.93% of the class. First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC collectively reported beneficial ownership of 593,278 Ordinary Shares, or 2.33% of the class. The filers state the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report passive ownership of Class A ordinary shares of Inflection Point Acquisition Corp. IV. They beneficially own 3,244,391 Class A shares, representing 12.8% of the class, with shared voting and shared dispositive power over all reported shares.
The filing is made on Schedule 13G, which is used for investments held in the ordinary course of business. The reporting persons certify the holdings were not acquired and are not held to change or influence control of the company.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report passive ownership of Class A ordinary shares of Inflection Point Acquisition Corp. IV. They beneficially own 3,244,391 Class A shares, representing 12.8% of the class, with shared voting and shared dispositive power over all reported shares.
The filing is made on Schedule 13G, which is used for investments held in the ordinary course of business. The reporting persons certify the holdings were not acquired and are not held to change or influence control of the company.
Inflection Point Acquisition Corp. IV filed an amended S-4/proxy to register up to 164,748,772 shares of New Merlin Common Stock in connection with its proposed business combination with Merlin Labs, Inc., along with 10,288,021 shares of Series A Preferred Stock, New Merlin Series A Warrants, 25,425,000 rights and 453,821 units.
The deal values Merlin at a purchase price of $800,000,000, with Merlin equity holders receiving New Merlin Common Stock based on a share exchange ratio tied to the SPAC’s per‑share trust redemption price. Pre‑Funded PIPE investors previously provided about $87.3 million in convertible notes and warrants, and additional PIPE investors committed $120 million for Series A Preferred Stock and warrants.
Inflection Point will domesticate from the Cayman Islands to Delaware, be renamed “Merlin, Inc.”, and seek Nasdaq listing under the symbol “MRLN”, although the listing condition may be waived, meaning the combined company’s stock might trade off-exchange. Public shareholders can redeem their Class A shares for cash (about $10.52 per share as of the record date) regardless of how they vote, but high redemptions and sponsor/insider equity and fees may significantly dilute non‑redeeming holders.
Inflection Point Acquisition Corp. IV filed an amended S-4/proxy to register up to 164,748,772 shares of New Merlin Common Stock in connection with its proposed business combination with Merlin Labs, Inc., along with 10,288,021 shares of Series A Preferred Stock, New Merlin Series A Warrants, 25,425,000 rights and 453,821 units.
The deal values Merlin at a purchase price of $800,000,000, with Merlin equity holders receiving New Merlin Common Stock based on a share exchange ratio tied to the SPAC’s per‑share trust redemption price. Pre‑Funded PIPE investors previously provided about $87.3 million in convertible notes and warrants, and additional PIPE investors committed $120 million for Series A Preferred Stock and warrants.
Inflection Point will domesticate from the Cayman Islands to Delaware, be renamed “Merlin, Inc.”, and seek Nasdaq listing under the symbol “MRLN”, although the listing condition may be waived, meaning the combined company’s stock might trade off-exchange. Public shareholders can redeem their Class A shares for cash (about $10.52 per share as of the record date) regardless of how they vote, but high redemptions and sponsor/insider equity and fees may significantly dilute non‑redeeming holders.
Barclays PLC reported beneficial ownership of 1,755,135 shares of Bleichroeder Acquisition Corp common stock, representing 6.90% of the class as of the event dated 12/31/2025. Barclays has sole voting and sole dispositive power over all these shares and no shared voting or dispositive power.
The position is reported on a Schedule 13G, indicating the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the company. Subsidiaries identified in connection with this holding include Barclays Bank PLC and Barclays Capital Inc.
Barclays PLC reported beneficial ownership of 1,755,135 shares of Bleichroeder Acquisition Corp common stock, representing 6.90% of the class as of the event dated 12/31/2025. Barclays has sole voting and sole dispositive power over all these shares and no shared voting or dispositive power.
The position is reported on a Schedule 13G, indicating the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the company. Subsidiaries identified in connection with this holding include Barclays Bank PLC and Barclays Capital Inc.